EVS Broadcast Equipment reports update of share buyback program EVS reports update of share buyback program Liège, Belgium | April 14, 2025 EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on November 25, 2024, took place between April 7 and 11, 2025: Trade DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)Market07-04-254,00032.258533.2031.35129,034XBRU08-04-254,00034.482235.3033.55137,929XBRU09-04-254,00033.581034.0033.00134,324XBRU10-04-254,000...
EVS Broadcast Equipment: update du programme de rachat d’actions propres EVS publie un update de son programme de rachat d'actions propres Liège, Belgique | Le 14 avril 2025 EVS Broadcast Equipment rapporte que les transactions suivantes, réalisées dans le cadre du programme de rachat d'actions annoncé le 25 novembre 2024, ont eu lieu entre le 7 et le 11 avril 2025: Date de la transactionNombre d’actions acquisesPrix moyen (EUR)Prix le plus haut (EUR)Prix le plus bas (EUR)Total (EUR)Marché07-04-254.00032,258533,2031,35129.034XBRU08-04-254.00034,482235,3033,55137.929XBRU09-04-254.00033...
A director at EVS Broadcast Equipment SA sold 54,406 shares at 36.761EUR and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Trumps reciprocal tariffs caused a massive blow to equity markets, following a pressured period of escalating trade wars. Retaliatory measures can further heavily damage market confidence, as seen Friday when China announced their 34% tarrif of US goods. International trade policies have never moved this erratic and untransparant, with uncertainty and volatility being the baseline for now. In this report we highlight the key stocks in our coverage relevant to this discussion.
EVS Broadcast Equipment reports update of share buyback program EVS reports update of share buyback program Liège, Belgium | April 7, 2025 EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on November 25, 2024, took place between March 31 and April 4, 2025: Trade DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)Market31-03-252,01137.717737.7537.5575,850XBRU01-04-2511837.750037.7537.754,455XBRU02-04-254,00037.545837.7537.35150,183XBRU03-04-254,000...
EVS Broadcast Equipment: update du programme de rachat d’actions propres EVS publie un update de son programme de rachat d'actions propres Liège, Belgique | Le 7 avril 2025 EVS Broadcast Equipment rapporte que les transactions suivantes, réalisées dans le cadre du programme de rachat d'actions annoncé le 25 novembre 2024, ont eu lieu entre le 31 mars et le 4 avril 2025: Date de la transactionNombre d’actions acquisesPrix moyen (EUR)Prix le plus haut (EUR)Prix le plus bas (EUR)Total (EUR)Marché31-03-252.01137,717737,7537,5575.850XBRU01-04-2511837,750037,7537,754.455XBRU02-04-254.00037,...
In this April 2025 update of the KBC Securities' Dynamic Top Pick List, we are removing Gimv and adding Adyen. Since adding Gimv to the Dynamic Top Pick List in mid-December 2024, Gimv's performance has remained flat. However, month-to-date, it has increased by nearly 7%, while the indices have all declined. Given the backdrop of a tariff war brewing, we think it's time to remove Gimv from the Dynamic Top Pick List as medium-sized businesses are more likely to feel the pinch of lower demand and...
EVS Broadcast Equipment reports update of share buyback program EVS reports update of share buyback program Liège, Belgium | March 31, 2025 EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on November 25, 2024, took place between March 24 and 28, 2025: Trade DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)Market24-03-25----- 25-03-25----- 26-03-254,00037.704037.7537.50150,816XBRU27-03-251,84837.704737.7537.5569,678XBRU28-03-252,52637.699937.753...
EVS Broadcast Equipment: update du programme de rachat d’actions propres EVS publie un update de son programme de rachat d'actions propres Liège, Belgique | Le 31 mars 2025 EVS Broadcast Equipment rapporte que les transactions suivantes, réalisées dans le cadre du programme de rachat d'actions annoncé le 25 novembre 2024, ont eu lieu entre le 24 et le 28 mars 2025: Date de la transactionNombre d’actions acquisesPrix moyen (EUR)Prix le plus haut (EUR)Prix le plus bas (EUR)Total (EUR)Marché24-03-25----- 25-03-25----- 26-03-254.00037,704037,7537,50150.816XBRU27-03-251.84837,704737,7537,5...
EVS Broadcast Equipment reports update of share buyback program EVS reports update of share buyback program Liège, Belgium | March 24, 2025 EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on November 25, 2024, took place between March 17 and 21, 2025: Trade DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)Market17-03-251.86037.739537.7537.7070.195XBRU18-03-25----- 19-03-25----- 20-03-25----- 21-03-25----- Total1.86037.739537.7537.7070.195 As ...
EVS Broadcast Equipment: update du programme de rachat d’actions propres EVS publie un update de son programme de rachat d'actions propres Liège, Belgique | Le 24 mars 2025 EVS Broadcast Equipment rapporte que les transactions suivantes, réalisées dans le cadre du programme de rachat d'actions annoncé le 25 novembre 2024, ont eu lieu entre le 17 et le 21 mars 2025: Date de la transactionNombre d’actions acquisesPrix moyen (EUR)Prix le plus haut (EUR)Prix le plus bas (EUR)Total (EUR)Marché17-03-251,86037,739537,7537,7070,195XBRU18-03-25----- 19-03-25----- 20-03-25----- 21-03-25----- To...
Arcadis: Further in German rail. CVC Capital Partners: They beat, they score. D'Ieteren: US Belron peer Boyd 4Q24 a bit ahead, weak 2025 early outlook. Fastned: Preview FY24. IBA: 2H24 better REBIT, net cash but outlook on the low side. Proximus: Interim leadership announced. UCB: Peer Immunovant reports mixed results in gMG Zabka: Peer Jeronimo Martins FY24 results
UCB presented results from studies involving doxecitine (dC) and doxribtimine (dT) (pyrimidine nucleoside therapy) in people living with thymidine kinase 2 deficiency (TK2d), at the MDA Clinical and Scientific Conference, being held 16-19 March in Dallas. The improvements in survival and functional outcomes highlight the potential of doxecitine and doxribtimine in treating TK2d, which is an ultra-rare genetic mitochondrial disease with no approved therapies, and has a prevalence of 1.64/1m peopl...
EVS Broadcast Equipment reports update of share buyback program EVS reports update of share buyback program Liège, Belgium | March 17, 2025 EVS Broadcast Equipment reports that the following transactions, conducted within the framework of the share buyback program announced on November 25, 2024, took place between March 10 and 14, 2025: Trade DateNumber of shares acquiredAverage price (EUR)Highest price (EUR)Lowest price (EUR)Total (EUR)Market10-03-257,81137.306537.4037.05291,401XBRU11-03-257,95637.340437.5037.15297,080XBRU12-03-256,15737.614937.7037.30231,595XBRU13-03-257,97...
EVS Broadcast Equipment: update du programme de rachat d’actions propres EVS publie un update de son programme de rachat d'actions propres Liège, Belgique | Le 17 mars 2025 EVS Broadcast Equipment rapporte que les transactions suivantes, réalisées dans le cadre du programme de rachat d'actions annoncé le 25 novembre 2024, ont eu lieu entre le 10 et le 14 mars 2025: Date de la transactionNombre d’actions acquisesPrix moyen (EUR)Prix le plus haut (EUR)Prix le plus bas (EUR)Total (EUR)Marché10-03-257.81137,306537,4037,05291.401XBRU11-03-257.95637,340437,5037,15297.080XBRU12-03-256.15737,...
At the American Academy of Dermatology (AAD) 2025 conference, UCB presented strong 5-year follow-up data for Bimzelx in plaque psoriasis and 2-year follow-up in hidradenitis suppurativa. Meanwhile, Johnson & Johnson also announced Phase 3 data for its oral drug icotrokinra in psoriasis, showing promising results and planning further trials. In addition, Amgen reported positive Phase 3 results for rocatinlimab in atopic dermatitis. These developments highlight significant advancements in dermatol...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.